GlassScriptPhysician profile
Philip Cheung Lee
NPI 1063699460
$3,958.28
in general payments reported to CMS, 2019-2025
33 companies · $527 in 2025
The $527 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,060 · 2020: $14.28 · 2021: $86.13 · 2022: $95.51 · 2023: $584 · 2024: $1,590 · 2025: $527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,701.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $616.43 | 2019-2025 | Watchman Flx, Rhythmia Mapping System |
| Novartis Pharmaceuticals Corporation | $565.47 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $466.07 | 2019-2025 | Farxiga, Brilinta, Wainua |
| Kestra Medical Technology Services, INC. | $449.94 | 2023-2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $379.13 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $184.40 | 2019-2025 | Camzyos, Eliquis |
| Kiniksa Pharmaceuticals International, Plc | $142.07 | 2024 | Arcalyst |
| Amgen INC. | $128.41 | 2019-2024 | Repatha |
| Sanofi-Aventis U.S. LLC | $122.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.63 | 2019-2024 | Jardiance |
| Novo Nordisk INC | $85.52 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Regeneron Healthcare Solutions, INC. | $80.35 | 2019 | |
| Irhythm Technologies, INC. | $58.26 | 2024 | Zio Xt Patch, Zio Monitor |
| Astellas Pharma US INC | $58.13 | 2019 | |
| Stryker Corporation | $46.59 | 2025 | Flowtriever |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $45.65 | 2024 | Symplicity G3 |
| Pfizer INC. | $42.26 | 2019 | |
| Amarin Pharma, INC. | $39.54 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.37 | 2023-2024 | |
| Heartflow, INC. | $35.36 | 2025 | |
| Edwards Lifesciences Corporation | $32.66 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $27.58 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $26.22 | 2019 | |
| Scpharmaceuticals INC. | $25.12 | 2025 | |
| Cvrx, INC. | $23.48 | 2025 | Barostim Neo System |
| Vifor Pharma, INC. | $22.92 | 2019 | |
| Alnylam Pharmaceuticals INC. | $22.21 | 2025 | |
| Mindray Ds USA, INC. | $20.88 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.58 | 2024 | Lifevest |
| Lantheus Medical Imaging, INC. | $16.50 | 2023 | Definity |
| Impulse Dynamics (USA) INC. | $15.40 | 2024 | Optimizer |
| Daiichi Sankyo INC. | $15.09 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $14.06 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.